Clinical trial
CS DNA MVA Trial in Mampong, Ghana
NCT00377494 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Withdrawn
Key facts
| NCT number | NCT00377494 |
|---|---|
| Title | CS DNA MVA Trial in Mampong, Ghana |
| Official title | A Phase I Trial of PFCSP DNA/MVA.CSO Prime/Boost Vaccine in Mampong, Ghana |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Withdrawn |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Plasmodium Falciparum Malaria |
| Intervention type | Biological |
| Interventions | MVA-CSO Vaccine, PfCSP DNA (VCL-2510) Vaccine |
| Enrollment | 0 |
| Completion | Jul 1, 2008 |
| First posted | Sep 18, 2006 |
| Last update posted | Jan 23, 2019 |
| Countries | Ghana, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: